Literature DB >> 21908506

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M Dreyling1, M Ghielmini, R Marcus, G Salles, U Vitolo.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21908506     DOI： 10.1093/annonc/mdr388

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  20 in total

1.  A multicenter survey of enteroscopy for the diagnosis of intestinal follicular lymphoma.

Authors:  Masaya Iwamuro; Hiroyuki Okada; Seiji Kawano; Junji Shiode; Ryuta Takenaka; Atsushi Imagawa; Tomoki Inaba; Seiyu Suzuki; Mamoru Nishimura; Motowo Mizuno; Masashi Araki; Tomohiko Mannami; Toru Ueki; Haruhiko Kobashi; Haruka Fukatsu; Shouichi Tanaka; Akiyoshi Omoto; Yoshinari Kawai; Takashi Kitagawa; Tatsuya Toyokawa; Katsuyoshi Takata; Tadashi Yoshino; Akinobu Takaki; Kazuhide Yamamoto
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

2.  Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties.

Authors:  Christian Klein; Alfred Lammens; Wolfgang Schäfer; Guy Georges; Manfred Schwaiger; Ekkehard Mössner; Karl-Peter Hopfner; Pablo Umaña; Gerhard Niederfellner
Journal:  MAbs       Date:  2012-12-04       Impact factor: 5.857

3.  Fc gamma receptor 3a genotype in follicular lymphoma: the end of the story? Reply to "Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone". Haematologica. 2012;97(6):937-942.

Authors:  Vít Procházka; Jana Gazdová; Tomás Papajík
Journal:  Haematologica       Date:  2012-11       Impact factor: 9.941

4.  Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study.

Authors:  Hugo J A Adams; Thomas C Kwee; Rob Fijnheer; Stefan V Dubois; Peter E Blase; Rutger A J Nievelstein; John M H de Klerk
Journal:  Skeletal Radiol       Date:  2014-06-06       Impact factor: 2.199

Review 5.  Pathogenesis of follicular lymphoma.

Authors:  Robert Kridel; Laurie H Sehn; Randy D Gascoyne
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

6.  Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma.

Authors:  Michael Herold; Christian W Scholz; Frank Rothmann; Carsten Hirt; Volker Lakner; Ralph Naumann
Journal:  J Cancer Res Clin Oncol       Date:  2015-03-25       Impact factor: 4.553

7.  Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party.

Authors:  Silvia Montoto; Paolo Corradini; Martin Dreyling; Michele Ghielmini; Eva Kimby; Armando López-Guillermo; Stephen Mackinnon; Robert E Marcus; Gilles Salles; Harry C Schouten; Anna Sureda; Peter Dreger
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

Review 8.  Current and future management of follicular lymphoma.

Authors:  Gilles Salles; Hervé Ghesquières
Journal:  Int J Hematol       Date:  2012-10-30       Impact factor: 2.490

Review 9.  Diagnosis of follicular lymphoma of the gastrointestinal tract: A better initial diagnostic workup.

Authors:  Masaya Iwamuro; Eisei Kondo; Katsuyoshi Takata; Tadashi Yoshino; Hiroyuki Okada
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 10.  Bendamustine: a review of its use in the management of chronic lymphocytic leukaemia, rituximab-refractory indolent non-Hodgkin's lymphoma and multiple myeloma.

Authors:  Sheridan M Hoy
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.